Autoimmune Encephalitis (AIE) Treatment Market Size
Market Size in USD Bn
CAGR9.2%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 9.2% |
| Market Concentration | Medium |
| Major Players | Roche Holding AG, Pfizer Inc., Novartis AG, Johnson & Johnson, Merck & Co., Inc. and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Autoimmune Encephalitis (AIE) Treatment Market Analysis
The autoimmune encephalitis (AIE) treatment market is estimated to be valued at USD 1.42 Billion in 2025 and is expected to reach USD 2.63 Billion by 2032, growing at a compound annual growth rate (CAGR) of 9.2% from 2025 to 2032. Factors such as rising incidences of autoimmune neurological disorders, increasing adoption of immune therapies, and growing awareness among patients about available treatments are expected to drive the autoimmune encephalitis (AIE) treatment market during the forecast period.